Liver protecting effects and molecular mechanisms of icariin and its metabolites

被引:5
|
作者
Ma, Yurong [1 ]
Zhao, Chong [1 ]
Hu, Hongbo [1 ]
Yin, Shutao [1 ]
机构
[1] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China
关键词
Epimedium brevicornum maxim; icariin; icaritin; metabolites; liver injury; prevention; pharmacokinetics; ISCHEMIA-REPERFUSION INJURY; PERFORMANCE LIQUID-CHROMATOGRAPHY; HEPATIC STELLATE CELLS; MESENCHYMAL STEM-CELLS; ICARISIDE II; PHYTOMOLECULE ICARITIN; OXIDATIVE STRESS; FIBROSIS; PATHWAY; INFLAMMATION;
D O I
10.1016/j.phytochem.2023.113841
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As a detoxification and metabolism organ, the liver plays a vital role in human health. However, an excessive consumption of drugs and toxins, exposure to pathogenic viruses, and unhealthy living habits can lead to liver damage, which may even develop into liver cirrhosis and liver cancer. Epimedium brevicornum Maxim. is a traditional Chinese medicine and dietary supplement in which the flavonoid icariin is a main functional component. Although the protective mechanisms of icariin and its metabolites against liver injury are not yet comprehensively understood, an increasing number of studies have confirmed their liver-protective and anticancer effects. Indeed, icaritin, one of the metabolites of icariin, is currently utilized as an active component of an anti-cancer drug. This paper presents a review of the molecular mechanisms through which icariin and its metabolites actively protect against the occurrence and development of liver injury, and, thus, provides a comprehensive reference for further research and their application in liver protection.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastic osteogenesis and its molecular mechanism
    Jia, Chunrong
    Liu, Hongxiao
    Li, Min
    Wu, Zhikui
    Feng, Xinghua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 9104 - 9109
  • [22] Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
    Zheng, Lingyan
    Wu, Sichen
    Jin, Haichao
    Wu, Jiaqi
    Wang, Xiaole
    Cao, Yuxiao
    Zhou, Zhihao
    Jiang, Yaona
    Li, Linhong
    Yang, Xinyue
    Shen, Qing
    Guo, Shunyuan
    Shen, Yuejian
    Li, Changyu
    Ji, Liting
    PHYTOMEDICINE, 2023, 116
  • [23] The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
    Zhang, Danyan
    Zhang, Yaguang
    Sun, Bing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [24] DIGITOXIN AND ITS METABOLITES IN PATIENTS WITH LIVER-CIRRHOSIS
    NOKHODIAN, A
    SANTOS, SRCJ
    KIRCH, W
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (02) : 207 - 213
  • [25] Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease
    Zhang, Jing
    Feng, Quansheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] The Biological Effects and Mechanisms of Fisetin on Hepatotoxicity, Liver Injury, and Liver Fibrosis: A Systematic Review
    Rahimian, Ghorbanali
    Heidari-Soureshjani, Saeid
    Kasiri, Karamali
    NATURAL PRODUCTS JOURNAL, 2024,
  • [27] Liver cirrhosis: molecular mechanisms and therapeutic interventions
    Dong, Zihe
    Wang, Yeying
    Jin, Weilin
    MEDCOMM, 2024, 5 (10):
  • [28] Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease
    Mao, Zi-Hui
    Gao, Zhong-Xiuzi
    Liu, Dong-Wei
    Liu, Zhang-Suo
    Wu, Peng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] Editorial: Molecular Mechanisms Protecting against Tissue Injury
    Wagener, Frank A. D. T. G.
    Immenschuh, Stephan
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [30] The Neuropharmacological Effects of Herba Epimedii and its Main Bioactive Components:Icariin,Icariside Ⅱ and Icartin
    XU Fan
    LEI Ming
    LONG Long
    GONG Qihai
    GAO Jianmei
    神经药理学报, 2017, 7 (02) : 29 - 29